Regenerative Medicine Market to reach USD 235.98 billion in 2032, and grow at a CAGR of 24.66%
The Regenerative Medicine Market is rapidly transforming healthcare by introducing groundbreaking solutions to repair, regenerate, and replace damaged tissues and organs. This innovative field leverages stem cell therapy, gene therapy, tissue engineering, and biomaterials to address chronic and degenerative conditions, including cardiovascular diseases, neurodegenerative disorders, musculoskeletal injuries, and genetic abnormalities. With over 1.13 million people globally requiring organ transplants annually but only a fraction receiving them due to donor shortages, regenerative medicine offers a promising alternative through lab-grown organs and bioengineered tissues.